This post has been de-listed
It is no longer included in search results and normal feeds (front page, hot posts, subreddit posts, etc). It remains visible only via the author's post history.
Hi team,
Has anyone seen any comment about a possible price when the eventually will launch the product. They're pretty silent on that part.
I ask this because this has major impact on the sales and in the past there have been a lot of pharmaceutical company's dropping drugs againt way to steap prices.
Thanks for your replies in advance!
Greets
We are quite a ways out from the medicine being priced.
Companies like Pfizer don’t wait until a new drug is already on the market. They buy in advance of phase-3 in most cases, and with Tamox earning $680M/yr (for AstraZ) with less efficacy and more side effects than Endox, the new owner will be pushing a hard marketing campaign to get the word out.
My prediction: ATOS will be bought out by Jan2025.
$40 isn’t random. If Endox replaces Tamox as SOC that’s a $5B valuation which is roughly $40/share.
Subreddit
Post Details
- Posted
- 1 year ago
- Reddit URL
- View post on reddit.com
- External URL
- reddit.com/r/AtossaThera...
How? They don’t even have an optimized dosage level yet, costs to mass produce, SGA, etc.
Plus, they’re investigating Endox for both treatment and prevention, which I’m sure will have different factors.
They would only be harming themselves to throw out a number at this point.